Pliva, Eastern Europe's biggest drug maker by sales, saw its profits take a massive dive in the first quarter of 2006, as a huge loss of royalties could not be offset by the relatively small growth in its generics business.
In-PharmaTechnologist.com (http://www.in-pharmatechnologist.com/news/ng.asp?n=67767-pliva-actavis-generics-azithromycin)
